Coverage of early-stage science, platform technologies, R&D innovation, and emerging companies shaping the future of medicine. From discovery breakthroughs to financing rounds and pipeline progress, this section tracks the momentum driving the biotech ecosystem.
Quick Summary Contract Value: $1.24 billion—the largest single contract for Samsung Biologics to date. Client: An Asia-based pharmaceutical company. Production Location: Songdo, South Korea, at
Quick Summary Investment Amount: Agomab Therapeutics raised $89 million in Series D financing. Key Backers: Led by new investors Sanofi and Invus, with participation from
Merck & Co. has acquired Modifi Biosciences, a precision oncology biotech, in a deal that includes a $30 million upfront payment and potential milestones totaling
Resolution Therapeutics has secured $85 million in new funding to continue developing its macrophage-based therapies for liver diseases. The company is leveraging the natural regenerative
In an exciting new development, Booster Therapeutics has entered the biotech space with a $15 million seed funding round. The company, which officially launched on
Cambridge-based biotech company Shift Bioscience has raised $16 million in seed funding to drive forward its cellular reprogramming research aimed at combating age-related diseases. The
The healthcare landscape is evolving rapidly, driven by groundbreaking advancements in biotechnology, medical technology, and pharmaceuticals. As investors and industry observers look ahead to 2025,
Biotechnology is advancing rapidly, driving innovation across healthcare, agriculture, food, and manufacturing. At the forefront of these advancements are gene editing technologies like CRISPR/Cas9, which
As we move further into 2024, the medical technology industry continues to innovate at an incredible pace, bringing new devices that improve patient outcomes and
